Microsatellite instability in colorectal cancer
By: Matej Horvat and Borut Stabuc
Open Access
|Mar 2011References
- Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Colorectal cancer.2005;: 153-65.
- Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B.Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
- Cancer incidence in Slovenia 2007. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2010.
- Velenik V. Post-treatment surveillance in colorectal cancer.2010;: 135-41.
- Zhou YL, Boardman LA, Miller RC. Genetic testing for young-onset colorectal cancer: case report and evidence-based clinical guidelines.2010;: 57-61.
- Fearon ER, Vogelstein B. A genetic model for colorectal tumourogenesis.1990;: 759-67.
- West NJ, Courtney EDY, Poullis AP, Leicester RJ. Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention.2009;: 1680-7.
- Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability.2002;: 2447-54.
- Lynch JP, Hoops TC. The genetic pathogenesis of colorectal cancer.2002;: 775-810.
- Kondo Y, Issa JPJ. Epigenetic changes in colorectal cancer.2004;: 29-39.
- Kozuka S, Nogaki M, Ozeki T, Masumori S. Premalignancy of the mucosal polyp in the large intestine. Estimation of the periods required for malignant transformation of mucosal polyps.1975;: 494-500.
- Kinzler K, Vogelstein B. Gatekeepers and caretakers.1997;: 761-3.
- Grady WM. Genomic instability and colon cancer.2004;: 11-27.
- Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, et al. The onset and extent of genomic instability in sporadic colorectal tumour progression.1999;: 15121-6.
- Law DJ, Olschwang S, Monpezat J-P. Concerted nonsystemic allelic loss in human colorectal carcinoma.1988;: 961-5.
- Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail.1997;: 315-21.
- Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal tumour development.1988;: 525-32.
- Powell SM, Zilz N, Beazer-Barclay Y. APC mutations occur early during colorectal oncogenesis.1992;: 235-7.
- Lenglauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers.1997;: 623-7.
- Jass JR, Whitehall VLJ, Young J, Leggett BA. Emerging concepts in colorectal neoplasia.2002;: 862-76.
- Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon.1993;: 816-9.
- Worthley DL, Leggett BA. Colorectal cancer: Molecular features and clinical opportunities.2010;: 31-8.
- De la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer.2010;: 3380-7.
- Radman M, Wagner R. Carcinogenesis. Missing mismatch repair.1993;: 722.
- McClulloch SD, Kunkel TA. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases.2008;: 148-61.
- Eshleman JR, Markowitz SD. Mismatch repair defects in human carcinogenesis.1996;: 1489-94.
- Umar A, Boland CR, Terdiman JP. Revised Bethesda guidelines for hereditary non-poliposis colorectal cancer (Lynch syndrome) and microsatellite instability.2004;: 261-8.
- Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, et al. Mismatch repair status in the prediction of benefit from adjuvant Flourouracil chemotherapy in colorectal cancer.2006;: 848-55.
- Niv Y. Microsatellite instability and MLH1 promoter hypermetalition in colorectal cancer.2007;: 1767-9.
- Liang JT, Huang KC, Lai HS, Lee PH, Cheng YM, Hsu HC, et al. High frequency microsatellite instability predicts better chemosensitivity to high dose 5-fluorouracil plus Leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection.2002;: 519-25.
- Markowitz S, Wang J Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.1995;: 1336-8.
- Lawes DA, SenGupta S, Boulos PB. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer.2003;: 201-12.
- Modrich P. Mechanisms and biological effects of mismatch repair.1991;: 229-53.
- Joseph N, Duppatla V, Rao DN. Prokaryotic DNA mismatch repair.2006;: 1-49.
- Iyer R, Pluciennik A, Modrich P, Modrich PL. DNA mismatch repair: functions and mechanisms.2006;: 302-23.
- Hsieh P, Yamane K. DNA mismatch repair: Molecular mechanisms, cancer and ageing.2008;: 391-407.
- Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorogenesis that persists after transformation.1994;: 273-81.
- Warusavitarne J, Schnitzler M. The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer.2007;: 739-48.
- Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer.1993;: 812-6.
- Gryfe R, Kim H, Hsieh ETK, Aronson MD, Holowaty EJ, Bull SB et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.2000;: 69-77.
- Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.2000;: 921-8.
- Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis.2005;: 609-18.
- Lim SB, Jeong SY, Lee MR, Ku JL, Shin YK, Kim WH, et al. Prognostic signifance of microsatellite instability in sporadic colorectal cancer.2004;: 533-7.
- Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehmé A, et al. The role of DNA mismatch repair in platinum drug resistance.1996;: 4881-6.
- Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, et al. The role of hMLH1, hMSH3 and hMSH6 defects in Cisplatin and Oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.1998;: 3579-85.
- Bras-Goncalves RA, Rosty C, Laurent-Puig P, Soulié P, Dutrillaux B, Poupon MF. Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status.2000;: 913-23.
- Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, et al. Loss of DNA mismatch repair in acquired resistance to Cisplatin.1996;: 3087-90.
- Fallik D, Borrini F, Boige V, Viguier J, Jacob S, Miquel C, et al. Microsatellite instability is a predictive factor of the tumor response to Irinotecan in patients with advanced colorectal cancer.2003;: 5738-44.
- Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S. Mortality associated with Irinotecan plus bolus Flourouracil/Leucovorin. Summary findings of an independent panel.2001;: 3801-7.
- Braun MS, Richman SD, Thompson L, Daly CL, Meade AM, Adlard JW, et al. Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS trial.2009;: 5519-28.
- Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma.2009;: 1-8.
- Adlard JW, Richman SD, Seymour MT, Quirke P. Prediction of the response of colorectal cancer to systemic therapy.2002;: 75-82.
- Fischer F, Baerenfaller K, Jiricny J. 5-flourouracil is efficiently removed from DNA by the base excision and mismatch repair systems.2007;: 1858-68.
- Ricciardiello L, Ceccarelli C, Angiolini G, Pariali M, Chieco P, Paterini P, et al. High tymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.2005;: 4234-40.
- Tajima A, Hess MT, Cabrera BL, Kolodner RD, Carethers JM. The mismatch repair complex hMutS alpha recognizes 5-flourouracil modified DNA: implications for chemosensitivity and resistance.2004;: 1678-84.
- Carethers JM, Chauhan DP, Fink D, Nebel S, Bresalier RS, Howell SB, et al. Mismatch repair proficiency and in vitro response to 5-flourouracil.1999;: 123-31.
- Kirchner T, Jung A. Pathologische Diagnostik fuer die individualisierte Therapie des Dickdarmkarzinoms.2010;: 16-21.
- Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, et al. The efficacy of adjuvant chemotherapy with 5-flourouracil in colorectal cancer depends on the mismatch repair status.2009;: 365-73.
- Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from Flourouracil-based adjuvant chemotherapy for colon cancer.2003;: 247-57.
- Magrini R, Bhonde MR, Hanski M, Notter M, Scherübl H, Boland CR. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.2002;: 23-31.
- Chamara M, Edmonston TB, Burkholder S, Walters R, Anne P, Mitchell E, et al. Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy.2004;: 3161-7.
- Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance.1998;: 1-6.
- Claij N, te Riele H. Microsatellite instability in human cancer: a prognostic marker for chemotherapy?1999;: 1-10.
- Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.2009;: 1890-6.
- Des Guetz G, Uzzan B, Nicolas P, Schischmanoff O, Perret GY, Morere JF. Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis.2009;: 1615-20.
- Des Guetz G, Mariani P, Cucherousset J, Benamoun M, Lagorce C, Sastre X et al. Microsatellite instability and sensitivity to FOLFOX treatment in metastatic colorectal cancer.2007;: 2715-19.
- Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Microsatellite instability as a marker of prognosis and response to therapy. A meta analysis of colorectal cancer survival data.2010;: 2788-98.
- Sinicrope F, Foster NR, Sargent DJ, Thibodeau SN, Smyrk TC, O'Connell MJ et al. Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients.2010;: 1691-8.
Language: English
Page range: 75 - 81
Published on: Mar 15, 2011
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2011 Matej Horvat, Borut Stabuc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.